L10 – Gynaecopathology: Genetics-Driven Cancers of the Ovary and Fallopian Tube Flashcards

1
Q

What are the key anatomical features of the ovary?

A

The ovary consists mainly of stromal cells that support maturing germ cells and is covered by a monolayer of modified mesothelium (the ovarian surface epithelium).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How is ovarian histology significant in tumour development?

A

The ovarian surface epithelium, though mesothelial in origin, can undergo metaplasia to a Müllerian phenotype, giving rise to epithelial tumours.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the epidemiological trend of ovarian cancer?

A

Ovarian cancer is the eighth most common cancer in women, with significant geographical variation and a declining incidence in some areas.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which factors are protective against ovarian cancer?

A

Protective factors include contraceptive pill use, high parity, breastfeeding, tubal ligation, and hysterectomy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are important risk factors for ovarian cancer?

A

Risk factors include family history, BRCA1/2 mutations, endometriosis, and certain hereditary syndromes (e.g. Lynch syndrome, Peutz-Jeghers).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How were ovarian epithelial tumours traditionally classified?

A

They were classified based on histological similarity to Müllerian epithelia, with categories including serous, endometrioid, clear cell, and mucinous tumours.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the traditional view of the cell of origin for ovarian tumours?

A

The traditional view posits that tumours originate from the ovarian surface epithelium undergoing metaplasia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Why has the paradigm of ovarian tumour origin shifted recently?

A

New evidence suggests that many high-grade serous carcinomas may originate in the fallopian tube, as shown by precursor lesions like STIC.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the histological features of low-grade serous carcinoma?

A

They exhibit micropapillary or cribriform patterns, minimal cytological atypia, and generally have a more indolent course.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How is high-grade serous carcinoma characterised?

A

It features marked nuclear pleomorphism, high mitotic index, complex papillary structures, and is often associated with p53 mutations.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the typical clinical presentation of serous carcinomas?

A

They often present in postmenopausal women and may be bilateral, with high-grade tumours showing rapid progression.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How do molecular alterations differ between low- and high-grade serous carcinomas?

A

Low-grade tumours show fewer mutations, while high-grade tumours frequently harbour TP53 mutations and display genomic instability.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What new evidence has emerged regarding the origin of high-grade serous carcinoma?

A

Studies indicate that many such tumours originate from the fallopian tube epithelium, with precursor lesions identified at the fimbrial end.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How does tubal ligation affect ovarian cancer risk?

A

Tubal ligation has been shown to reduce the incidence of high-grade serous and other ovarian carcinomas by interrupting the proposed seeding from the fallopian tube.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the clinical implications of the shift in tumour origin paradigms?

A

It may lead to revised screening strategies, risk-reducing procedures, and tailored therapies for ovarian and tubal cancers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Why is genetic profiling important in managing ovarian cancer?

A

Genetic profiling helps identify BRCA mutations and other molecular alterations, which can guide targeted therapies and inform prognosis.

17
Q

What clinical impact do BRCA1/2 mutations have on ovarian cancer management?

A

They increase risk, guide decisions on prophylactic surgeries, and indicate suitability for PARP inhibitors.

18
Q

How does the fallopian tube hypothesis influence ovarian cancer screening?

A

It suggests that early detection should also target the fallopian tubes, potentially altering diagnostic protocols.

19
Q

What role do tumour markers such as CA-125 play in ovarian cancer?

A

They assist in screening, monitoring treatment response, and may help indicate recurrence, though specificity is limited.

20
Q

How does histological heterogeneity in ovarian tumours affect treatment planning?

A

Diverse subtypes necessitate tailored therapies and impact prognosis, making precise classification crucial.

21
Q

What is the anatomical relationship between the ovaries and fallopian tubes?

A

The ovaries are located bilaterally in the pelvis, positioned near the fallopian tubes to allow for ovum capture.

22
Q

How does the fallopian tube facilitate fertilization?

A

The fimbrial end of the fallopian tube opens to guide the ovum toward the uterine cavity, where fertilization typically occurs.

23
Q

What complications can arise from infections affecting the fallopian tubes?

A

Infections can cause adhesions, leading to infertility or an increased risk of ectopic pregnancy.

24
Q

Why is an ectopic pregnancy a medical emergency?

A

An ectopic pregnancy can rupture the fallopian tube, causing severe abdominal pain and internal bleeding, necessitating urgent medical intervention.

25
Q

How does polycystic ovarian syndrome affect ovarian size?

A

Polycystic ovarian syndrome can cause ovarian enlargement due to the accumulation of multiple immature follicles.

26
Q

What are the key structural components of the ovary?

A

The ovary consists of an outer cortex containing developing oocytes and a deeper medulla that supports vascular structures.

27
Q

How does the mesothelial lining of the ovary compare to other body surfaces?

A

The ovarian mesothelium is similar to that of the chest wall, providing a protective but functionally significant covering.

28
Q

Why is ovarian cancer often diagnosed at an advanced stage?

A

Ovarian cancer remains asymptomatic in early stages, leading to late-stage detection and poorer outcomes.

29
Q

How have recent classification updates changed the categorization of ovarian tumors?

A

Some previously malignant ovarian tumors are now classified as borderline, reflecting a less aggressive clinical course.

30
Q

What genetic factors increase the risk of ovarian cancer?

A

BRCA1 and BRCA2 mutations, as well as Lynch syndrome, significantly elevate the risk of ovarian cancer.

31
Q

Which protective factors help reduce ovarian cancer risk?

A

Contraceptive use, high parity, and surgical procedures such as tubal ligation help reduce ovarian cancer risk.

32
Q

Why is imaging becoming more important in ovarian tumor detection?

A

Advanced imaging techniques are improving the early detection of ovarian tumors, even in asymptomatic cases.

33
Q

How do low-grade and high-grade serous carcinomas differ in prognosis?

A

Low-grade serous carcinoma has a more indolent course, while high-grade serous carcinoma tends to be aggressive with a poorer prognosis.

34
Q

What histological features distinguish low-grade from high-grade serous carcinoma?

A

Low-grade serous carcinoma shows a papillary growth pattern with minimal atypia, whereas high-grade serous carcinoma exhibits significant cellular atypia, high mitotic activity, and invasive behavior.

35
Q

How does BRCA mutation status impact ovarian cancer treatment?

A

BRCA mutations guide treatment decisions, particularly the use of targeted therapies such as PARP inhibitors.

36
Q

Why is the classification of ovarian tumors evolving over time?

A

Ongoing research and genetic discoveries are refining tumor classification and influencing treatment strategies.